Interventions for Addiction

Interventions for Addiction

Comprehensive Addictive Behaviors and Disorders, Volume 3

1st Edition - February 26, 2013
This is the Latest Edition
  • Editor-in-Chief: Peter Miller
  • eBook ISBN: 9780123983633

Purchase options

Purchase options
DRM-free (Mobi, EPub, PDF)
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

Interventions for Addiction examines a wide range of responses to addictive behaviors, including psychosocial treatments, pharmacological treatments, provision of health care to addicted individuals, prevention, and public policy issues. Its focus is on the practical application of information covered in the two previous volumes of the series, Comprehensive Addictive Behaviors and Disorders. Readers will find information on treatments beyond commonly used methods, including Internet-based and faith-based therapies, and criminal justice interventions. The volume features extensive coverage of pharmacotherapies for each of the major drugs of abuse—including disulfiram, buprenorphine, naltrexone, and others—as well as for behavioral addictions. In considering public policy, the book examines legislative efforts, price controls, and limits on advertising, as well as World Health Organization (WHO) efforts. Interventions for Addiction is one of three volumes comprising the 2,500-page series, Comprehensive Addictive Behaviors and Disorders. This series provides the most complete collection of current knowledge on addictive behaviors and disorders to date. In short, it is the definitive reference work on addictions.

Key Features

  • Includes descriptions of both psychosocial and pharmacological treatments.
  • Addresses health services research on attempts to increase the use of evidence-based treatments in routine clinical practice.
  • Covers attempts to slow the progress of addictions through prevention programs and changes in public policy.

Readership

Researchers and students in psychology, psychiatry, neuroscience and neurology

Table of Contents

  • Preface

    Scope and Format

    Volume 3: Interventions for Addictions

    Editors: Biographies

    List of Contributors

    Section 1: Treatment

    Chapter 1. Brief Feedback-Focused Interventions

    Definition

    The Development of Brief Feedback-Focused Interventions

    Role in Overall Treatment

    Goals of BFIs

    Proposed Active Ingredients of BFIs

    Behaviors Addressed by BFIs

    Feedback Content

    Modalities

    Populations

    Summary

    Chapter 2. Motivational Enhancement Approaches

    Introduction

    What Is Motivational Interviewing?

    What Is Not Motivational Interviewing?

    Principles

    Techniques

    Handling Resistance

    Empirical Support

    Other Applications

    Learning Motivational Interviewing

    Dissemination of Motivational Interviewing

    Future Research Directions

    Conclusions

    See also

    Chapter 3. Cognitive Behavioral Therapies

    Introduction

    History and Theoretical Underpinnings

    Defining Elements of CBT

    Empirical Support for CBT

    Novel Methods of Delivery and Dissemination

    Summary

    See also

    Chapter 4. Cue Exposure Treatments for Substance Use Disorders

    Theoretical Rationale for CET

    General Principles of CET

    Assessments Used in CET

    Cue Exposure with Urge Coping Skills for AUDs

    Evidence-Based Effectiveness of CET

    See also

    Chapter 5. Contingency Management

    Introduction

    Reinforcers

    Issues Central to CM

    Efficacy

    Dissemination and Uptake Challenges

    Summary

    See also

    Chapter 6. Community Reinforcement Approaches: CRA and CRAFT

    Community Reinforcement Approach: CRA

    CRA Procedures

    CRA Scientific Support

    Community Reinforcement and Family Training: CRAFT

    CRAFT Procedures

    CRAFT Scientific Support

    Conclusion

    See also

    Chapter 7. Behavioral Couples Therapy for Alcoholism

    Introduction

    Bi directional Association between Alcoholism and Intimate Relationships

    Overview of BCT and Its Major Components

    Empirical Support for BCT

    Contraindications and Challenges to Using BCT

    Future Directions

    Summary

    Chapter 8. Network Support Treatment for Alcohol Dependence

    Introduction

    The Problem of Relapse

    Encouraging Participation in Non–alcohol-related Activities

    The Social Network, AA, and Relapse

    Project MATCH

    The United Kingdom Alcohol Treatment Trial Social Behaviour and Network Therapy Study

    Network Support Treatment

    Structure of Network Support Treatment

    Session Topics: Core Topics and Electives

    Efficacy of Network Support Treatment

    Network Support: Conclusion

    See also

    Chapter 9. Multisystemic Therapy for Adolescent Substance Use

    Theoretical Bases of MST

    Characteristics of MST Treatment

    MST Treatment Principles and Process

    Empirical Bases for MST

    Dissemination of MST

    Conclusion

    See also

    Chapter 10. Multidimensional Family Therapy for Adolescent Substance Abuse: A Developmental Approach

    Ten Guiding Principles

    Characteristics of the Treatment Program

    Decision Rules About Individual, Family, or Extrafamilial Sessions

    Manuals and Other Supporting Materials

    Evidence on the Effects of Treatment

    Substance Abuse

    Substance Abuse-Related Problems

    School Functioning

    Psychiatric Symptoms

    Delinquent Behavior and Association with Delinquent Peers

    Theory-Related Change: Family Functioning

    Studies on the Therapeutic Process and Change Mechanisms

    Economic Analyses

    Implementation Research

    Conclusions

    Chapter 11. Brief Strategic Family Therapy for Adolescent Drug Abuse: Treatment and Implementation

    BSFT Principles

    The BSFT Intervention

    BSFT: The Intervention

    BSFT Engagement

    BSFT Restructuring Techniques

    BSFT and Culture

    BSFT Research: Therapy Process Studies and Outcome Evaluations

    BSFT Effectiveness

    BSFT Implementation

    Conclusions

    See also

    Chapter 12. Functional Family Therapy for Adolescent Substance Use Disorders

    Overview

    The Functional Family Therapy Model

    Evidence for the Effects of Treatment

    Training and Supervision

    Summary and Current Directions

    See also

    Chapter 13. Individual and Group Counseling for Substance Use Disorders

    Overview of the IDC and GDC Models

    Based on the Disease Model

    Focus on Behavioral Change

    Mutual Support Program Participation

    Family Involvement

    Drug Testing

    Preventing Relapse

    Lifestyle Changes

    Spirituality

    Stages of Recovery

    Themes in Treatment by Stage of Recovery

    Logistics of the Individual Counseling Session

    Combining Group and Individual Therapy

    Group Drug Counseling

    Logistics of the Group Counseling Session

    Strategies for Dealing with Common Problems in the IDC/GDC Model

    Research on the IDC/GDC Models

    Conclusions

    See also

    Chapter 14. Self-Help Groups

    Self-help Paradigm

    Significance

    Reasons for Group Participation

    Benefits

    Group Types

    Criticisms

    Summary

    See also

    Self-Help Clearing House

    Chapter 15. Twelve-Step Facilitation Therapy

    What Is Twelve-Step Facilitation Therapy?

    What Are TSOs?

    TSOs and Professional Treatment

    The Structure and Components of TSF Therapy

    Evaluations of TSF Therapy Delivered in Project MATCH

    Evaluations of TSF Therapy in Other RCTs

    Conclusions

    Chapter 16. Faith-Based Substance Abuse Programs

    The Structure of Faith-Based Treatment Programs

    The Twelve Steps of AA and Faith-Based Organizations

    Empirical Research and Faith-Based Substance Abuse Programs

    Summary of the Empirical Literature on Faith-Based Programs and Spirituality

    See also

    Chapter 17. Behavioral Treatments for Smoking

    Introduction

    Brief Clinical Interventions

    Intensive Interventions

    Specific Populations

    Alternative Strategies

    Challenges

    Conclusions

    See also

    Chapter 18. Behavioral Treatments for Adolescents with Substance Use Disorders

    Introduction

    Approaches

    Brief Treatments

    Combination Behavioral Treatments

    Effectiveness of Behavioral Approaches by Gender and Culture

    Summary

    See also

    Chapter 19. Gender-Specific Treatments for Substance Use Disorders

    Introduction

    Development of “Gender-Specific” Treatment for Women

    Profile of Women with Substance Use Problems

    Gender-Specific Treatment Approaches for Women

    Characteristics of Gender-Specific Treatment Services and Programs

    Outcomes of Women Treated in Gender-Specific Programs

    Gender-Specific Treatment Components Associated with Outcomes

    Methodological Issues in Research on Gender-Specific Treatment

    Evidence-Based Treatment Approaches for Women with Substance Use Disorders

    Conclusions

    See also

    Chapter 20. PTSD and Substance Abuse Treatment

    Psychological Trauma and PTSD

    Psychological Trauma, PTSD, and ASUD

    Psychological Trauma History and PTSD as Prognostic Factors in ASUD Treatment

    Integrated PTSD–ASUD Treatment Interventions

    Screening for PTSD in ASUD Treatment

    Conclusion

    See also

    Chapter 21. Criminal Justice Interventions

    Substance Abuse and Crime

    Sentencing Options

    Evidence-Based Sentencing

    Risk and Need Assessment

    Matching Dispositions by Risks and Needs

    Evidence-Based Treatments

    Prisoner Reentry

    Racial, Ethnic, and Gender Responsiveness

    Conclusion

    See also

    Chapter 22. Driving While Impaired (Treatments)

    Introduction

    Who Are DWI Drivers?

    Methodological Issues in Evaluating DWI Intervention Programs

    Conceptual Framework for Understanding DWI Intervention Effectiveness

    Universal Prevention Approaches for DWI

    Selective Prevention Approaches for DWI

    Indicated Prevention Approaches for DWI

    Conclusion

    See also

    Chapter 23. Mindfulness

    Introduction

    Mindfulness-Based Interventions

    Mindfulness Meditation and Addiction Recovery

    Mechanisms of the Clinical Effects of Mindfulness-Based Interventions

    Review of the Mindfulness Meditation and Addiction Treatment Literature

    Summary of Mindfulness-Based Interventions

    Future Directions for Research

    See also

    Chapter 24. Psychological Treatments for Pathological Gambling

    Pathological Gambling Nosology, Prevalence, and Demographic Correlates

    Diagnostic Issues and Assessment of Gambling Severity

    Psychological Treatment Options for PG

    Identifying the Most Important Factors to Address in CBT for PG

    Summary

    Chapter 25. HIV/AIDS and Substance Abuse

    Introduction

    History of AIDS Epidemic

    Trends in the HIV/AIDS Epidemic

    Transmission of HIV

    Criminal Justice Settings

    Prevention and Intervention Programs

    Summary

    See also

    Chapter 26. Treatment-as-Usual for Substance Abuse in Community Settings

    What Is Community-Based Treatment?

    TAU Based on National Survey Data

    Treatment Practices of Community Providers Based on Independent Evaluation

    Therapeutic Alliance and Client Outcome

    Limitations

    Conclusion and Future Directions

    See also

    Chapter 27. Disparities in Health Services for the Treatment of Substance Use Disorders

    Introduction

    Overall Low Utilization of Treatment for SUDs

    The Historical and Contemporary Policy Context

    New Policy Initiatives Affecting Disparities in the Delivery of SUD Treatment

    Sociocultural Vectors Affecting Disparities in SUD Treatment

    Definitional Contexts for Health Care Disparities in Treatment Delivery for SUDs

    Problematic Subgroups with Disparities in the Treatment of SUDs

    Dilemmas in Considering Disparities in Treatment for SUDs

    Specific Policies That Have Addressed Disparities in Treatment for SUDs

    Research Artifacts Affecting the Measurement of Health Disparities

    Conclusion

    See also

    Chapter 28. A Decade of Research on Recovery Management Checkups

    Managing Addiction as a Chronic Condition

    Evolution of the Recovery Management Checkup Model

    Discussion

    Strengths and Limitations

    Implications

    Chapter 29. Technology-Delivered Treatments for Substance Use Disorders: Current Status and Future Directions

    Introduction

    The Logic and Potential Benefits of Technology-Delivered Treatment (TDT)

    Current Status of TDT for Substance Abuse

    Future Directions of TDT: Content Development

    Future Directions of TDT: Technological Development

    Conclusion

    See also

    Chapter 30. Screening and Interventions in Medical Settings Including Brief Feedback-Focused Interventions

    Introduction

    Screening

    Brief Interventions

    Conclusions

    See also

    Chapter 31. Screening and Assessment of Comorbidity

    The Issue of Comorbidity

    Identifying How Disorders Are Related

    Purpose and Structure of the Chapter

    Psychometric Issues to Consider When Selecting a Measure of Comorbidity

    Screening for Mental Disorder in People with Addictive Disorders

    Screening for Addictive Disorder in People with Mental Disorder

    Diagnosis of Comorbidity

    Assessment of Symptoms

    Summary and Conclusions

    See also

    Chapter 32. Diagnostic Dilemmas in Comorbidity

    Introduction

    Common Comorbid Disorders

    Psychiatric Nomenclature and Comorbidity

    Structured Clinical Interviews

    Validity of Comorbid Diagnoses

    Alternative Models of Comorbidity

    Summary and Conclusions

    See also

    Chapter 33. Treatment for Co-occurring Substance Abuse and Mental Health Disorders

    Historical Treatment of Co-Occurring Disorders

    Integrated Treatment

    Research

    Conclusions

    See also

    Chapter 34. Implications of Comorbidity for Clinical Practice

    People with Co-Occurring Disorders Have a Right to Equal Access to Quality Care

    Co-Occurring Disorders Are Common and Often Have a Profound Impact

    Tobacco Smoking Is Endemic and Affects Morbidity, Mortality, and Functioning

    Co-Occurring Problems Are Often Multiple and Closely Interlinked

    Better Policies and Practices for Co-Occurring Disorders Require Organizational Change

    Conclusion

    See also

    Section 2: Medications to Treat Addictions

    Chapter 35. Medications to Treat Addictions: Nicotine Replacement

    Introduction

    Role of Nicotine in Tobacco Addiction

    History of NRT

    Mechanism of Action

    NRT Formulations

    Abuse Liability of NRTs

    Efficacy of NRTs

    NRT Combination Treatments

    Real-Word Effectiveness of NRTS

    Special Populations

    Personalized Medicine with NRTS

    See also

    Chapter 36. Non-Nicotine Medications

    Introduction

    Neurobiology of Nicotine and Tobacco

    Non-Nicotine Pharmacotherapies

    Other Non-Nicotine Pharmacotherapies

    Conclusion

    See also

    Chapter 37. Alcohol Detoxification

    Concept

    Epidemiology and Clinical Manifestations

    Assessment of AWS: Alcohol Withdrawal Scales and Biomarkers

    Pathophysiology

    Management of AWSs

    Complications of AWS

    Chapter 38. Disulfiram for Alcohol and Other Drug Use

    Introduction

    Effects of Disulfiram

    Disulfiram in Alcohol Use Disorders

    Comparisons and Combinations with Other Agents

    Disulfiram in Cocaine Use Disorders

    Disulfiram in the Dually Diagnosed

    Conclusions

    See also

    Chapter 39. Naltrexone and Opioid Antagonists for Alcohol Dependence

    Introduction

    Definition of the Problem

    Epidemiology

    Medical Approaches to Treatment

    Neurobiology of Alcohol Dependence and the Role of the Endogenous Opioid System

    Opioid Antagonists for the Treatment of Alcohol Dependence

    Future Directions

    Summary

    See also

    Chapter 40. Acamprosate for Alcohol Dependence

    Alcohol Dependence

    Neurobiology of Alcohol Dependence and Protracted Abstinence

    Medications to Treat Alcohol Dependence

    Overview of Acamprosate

    Mechanism of Action of Acamprosate

    Clinical Efficacy of Acamprosate

    Acamprosate Effects on Sleep

    Safety and Tolerability of Acamprosate

    Drug–Drug Interactions

    Concluding Remarks

    See also

    Chapter 41. Anticonvulsant Medications for the Treatment of Alcohol Dependence

    Introduction

    Pharmacological Treatments for Alcohol Dependence

    Summary and Conclusions

    Chapter 42. Medications for Treatment of Marijuana Dependence

    Marijuana Use and Neurobiology: A Brief Overview

    Marijuana Withdrawal

    Marijuana Dependence and Demand for Treatment

    Pharmacotherapy: Approaches for Substance Dependence

    Reducing Marijuana Withdrawal Symptoms in the Laboratory

    Blunting the Positive or the Reinforcing Effects of Marijuana in the Laboratory

    What Works in the Clinic?

    Directions for the Future

    See also

    Chapter 43. Methadone Maintenance

    Mechanism of Action of Opioids

    Pharmacologic Profile of Opioids

    Opioid Intoxication and Overdose

    Opioid Withdrawal

    Opioid Abuse and Dependence

    Utilization of Methadone for Treatment of Opioid Dependence

    Methadone Maintenance for Management of Opioid Craving

    Dosing Guidelines for MMT

    Drug to Drug Interaction with Methadone

    Retention in MMT

    Methadone Maintenance for Prevention of Illicit Opioid Overdose

    Management of Co-occurring Medical Conditions for Methadone-Maintained Patients

    Management of Co-occurring Acute Pain for Methadone-Maintained Patients

    Methadone Maintenance for Treatment of Opioid-Dependent Pregnant Women

    See also

    Chapter 44. Buprenorphine for Opioid Dependence

    Buprenorphine Opioid Agonist Therapy

    Improving Access to Opioid Agonist Therapy

    Pharmacology

    Clinical Considerations

    Treating Opioid Withdrawal Syndrome

    Induction, Stabilization, Maintenance, and Discontinuation

    Clinical Outcomes

    Use in Special Populations

    Access and Cost-Effectiveness of Buprenorphine Care

    Misuse and Diversion

    Summary

    See also

    Chapter 45. Antagonists for the Treatment of Opioid Dependence

    Introduction

    Rationale and Theoretical Background

    Clinical Background and the Compliance Problem

    The Development of Naltrexone Implants (NTXI) and Depot Injections of Naltrexone (DINTX)

    Pharmacokinetics of NTXI and DINTX

    Opioid Overdose Prevention

    Effectiveness Studies of NTXI and DINTX

    Local Side Effects

    Systemic Side Effects

    Mental Health after Implantation

    New Treatments, New Problems: Some Novel Phenomena Occasionally Appearing during NTXI and DINTX Treatment

    Cognitive-Behavioral Aspects of Depot and Implanted NTX Treatment

    How Long Should NTX Depot/Implant Treatment Last?

    Conclusion

    See also

    Chapter 46. Pharmacotherapy of Cocaine Dependence

    Introduction

    Rationale of Medication Targets for Cocaine Pharmacotherapy

    Clinical Studies of Pharmacotherapies for Cocaine Dependence

    Explaining Variability of Treatment Outcomes

    Conclusions and Future Directions

    See also

    Chapter 47. Agonist-Like (Substitution) Treatment for Cocaine and Other Stimulant Dependence

    Stimulant Use, Abuse, and Dependence

    Historical Perspective

    Prevalence

    Determinants of Cocaine and Other Stimulant Use Disorders

    Treatment Options for Stimulant Abuse and Dependence

    Goals of Agonist Treatment

    Factors Presumed Necessary for Effective Treatment and Diminished Risk

    Clinical Evaluations of Agonist-like Medications for Stimulant Dependence

    Impediments to Development and Approval of Agonist Medication for Stimulant Dependence

    Conclusion

    See also

    Chapter 48. Medication Development for Amphetamine Dependence

    Introduction

    Bupropion

    Naltrexone

    Dextroamphetamine

    Modafinil

    Methylphenidate

    Aripiprazole

    Baclofen

    Gamma-Vinyl-GABA

    Topiramate

    Gabapentin

    Varenicline

    Lobeline

    Rivastigmine

    Selective Serotonin Reuptake Inhibitors

    Ondansetron

    Perindopril

    Summary and Future Implications

    Chapter 49. Medications for Sedative Dependence

    Sedative Dependence

    Benzodiazepines

    Subgroups of Benzodiazepine-Dependent Patients

    Benzodiazepine Withdrawal Syndrome

    Neurobiological Actions of Benzodiazepines

    The Neurobiology of Benzodiazepine Dependence

    Model of the Development of Benzodiazepine Dependence

    Treatment of Benzodiazepine Dependence

    Conclusion

    Chapter 50. The Treatment of Depressed Alcoholics

    Definition of Co-Occurring Major Depression and of Alcohol Dependence

    Epidemiology of Co-Occurring Major Depression and Alcohol Dependence

    Onset and Course of Co-Occurring MDD/AD

    Treatment Utilization of Co-Occurring MDD/AD

    Antidepressant Pharmacotherapy for Adults with Co-Occurring MDD/AD

    Other Forms of Pharmacotherapy (Disulfiram, Lithium, Naltrexone, Acamprosate, Ondansetron, and Mood stabilizers) for Treating Co-Occurring MDD/AD

    Pharmacotherapy for Adolescents and Young Adults with Co-Occurring MDD/AD

    Twelve-Step Programs and Psychosocial Therapies for Co-Occurring MDD/AD

    Conclusions and Future Directions for Research involving Co-Occurring MDD/AD

    Conflicts of Interest

    See also

    Chapter 51. Medications for Comorbid Bipolar Disorder and Addiction

    Prevalence of Substance Use Disorders in People with Bipolar Disorder

    Impact of SUD on BPD Treatment and of BPD on SUD Treatment

    Treatment Considerations in Persons with Comorbid BPD and SUDs

    Conclusions

    See also

    Chapter 52. Treatment of Anxiety in Substance-Using Patients

    Definition of Anxiety Disorders

    Epidemiology

    Reasons for Comorbidity of Anxiety Disorders and Substance Use

    Prevention and Therapy

    Future Prospects

    See also

    Chapter 53. Comorbid Addictions and Schizophrenia

    Introduction

    Epidemiology

    Neurobiology of Addiction and Schizophrenia

    Course and Consequences of Dual Disorders

    Integrated Treatment

    Conclusion

    See also

    Chapter 54. Pain and Addiction

    Introduction

    Risk Factors for Addiction

    Diagnosing Addiction in the Opioid-Treated Pain Patient

    Guidelines

    Universal Precautions and Risk Stratification

    Managing Pain with Opioids: Maximizing Benefit and Minimizing Risk

    Strategies to Deter Opioid Abuse and Diversion

    Summary

    See also

    Chapter 55. The Treatment of Insomnia in Substance-Abusing Patients

    Introduction

    Methods

    Results

    Discussion

    Chapter 56. Medication for Cravings in Substance Use Disorders

    Medication for Craving and Mood

    Medications for Alcohol Craving

    Medications for Opioid Craving

    Medications for Stimulant Cravings

    Medications for Nicotine Craving

    Medications for Cannabis Craving

    Funding

    Disclosures

    See also

    Chapter 57. Vaccines for Addictive Disorders

    Introduction

    Vaccine Construction

    Antibody Theory and Expectations

    Morphine and Heroin

    Methamphetamine

    Cocaine

    Nicotine

    Bench to Patient Transition

    See also

    Chapter 58. Medications for Behavioral Addictions

    Introduction

    Pathological Gambling

    Kleptomania

    Compulsive Buying

    Compulsive Sexual Behavior

    Pyromania

    Internet Addiction

    Trichotillomania

    Pathological Skin Picking

    Intermittent Explosive Disorder

    Conclusions

    See also

    Section 3: Applying Addiction Science to Clinical Practice

    Chapter 59. Health Care Reforms and Treatment for Substance Use Disorders

    Introduction

    Substance Use Disorders and the Contemporary US Medical Care System

    Parity Legislation

    The Historical Platform for SUDs in Today’s Health Care Reform

    The Beginnings of Parity for SUDs Treatment

    Formalizing Treatment for SUDs

    The Organizational Basis for Integration of SUDs into Medical Care

    Toward Institutionalizing Treatment for Illegal Drug Dependence

    Creation of a Scientific Foundation for Treating SUDs

    Mechanisms for Mainstreaming and Integration of SUDs into Medical Care

    Barriers to the Integration of the Treatment of SUDs into Medical Care

    Challenges in the Implementation of Health Care Reform and the Treatment of SUDs

    Chapter 60. Improving the Quality of Addiction Treatment

    Improving the Quality of Addiction Treatment

    Need for Quality Addiction Treatment

    Strategies to Promote Quality Care

    Quality Improvement and Health care

    Improving the Delivery of Addiction Treatment

    Performance Measurement

    Addiction Treatment Quality in 2025

    Discussion

    See also

    Chapter 61. Evaluating Treatment Efficacy

    Study Design Considerations

    Analytic Methods to Evaluate Treatment Efficacy

    How to Interpret Results

    Conclusions

    See also

    Chapter 62. Economic Analysis of Addiction Treatment Programs

    Economic Analysis

    Costing Studies

    Economic Evaluation

    Cost-Function Analysis

    Summary

    See also

    Chapter 63. Ethical Issues in the Treatment of Drug Dependence

    Introduction

    Ethical Principles and Social Factors Influencing the Treatment of Addiction

    Autonomy and the Drug-Dependent Individual

    Personal Health and the Public Good

    Distributive Justice: Balancing the Burden of Disease and Treatment

    Entering Treatment for Addiction

    Coerced Treatment of Addiction

    Treatment of Vulnerable Populations

    Conclusion

    See also

    Chapter 64. Evidence-Based Treatment

    Introduction

    Evidence-Based Treatment

    Examples of Key Studies and Findings

    EBT in Practice

    Examples of Evidence-Based Treatments

    Current State of Treatment

    Conclusions and Future Directions

    See also

    Chapter 65. Harm Reduction Approaches

    Introduction

    History and Development

    Individualized Harm Reduction Strategies

    Environmental Strategies

    Examples of Age-Specific Psychological Interventions

    Summary and Future Directions

    See also

    Chapter 66. Therapeutic Communities

    Introduction

    Traditional TCs

    The TC Perspective

    The TC Approach: Community as Method

    The TC Program Model

    Therapeutic Community Methods

    The Program Stages and Phases

    Who Comes for Treatment?

    Research: The Effectiveness of Therapeutic Communities

    The Evolution of the TC: Modifications and Applications

    The TC Worldwide

    The TC in Human Services

    See also

    Chapter 67. Internet Screening and Intervention Programs

    Introduction

    What Is an Internet Intervention Application?

    Advantages of Computerized Applications

    Methodological Challenges in Evaluating Internet Interventions

    Challenges in the Development of Effective Internet Interventions

    Theoretical Background, Delivery Effectiveness, and Underlying Components

    Alcohol Interventions

    Tobacco Interventions

    Drug Interventions

    Other Addictive Behaviors

    Summary

    See also

    Chapter 68. Dissemination of Evidence-based Treatment into Practice

    Introduction and Background

    Effecting the Transition from Dissemination to Application – The Federal Role

    Achieving Program Change

    Conceptualizing the Change Process

    Developing a Science of Implementation

    Summary and Conclusions

    See also

    Chapter 69. Improving Medication Use in Addictions Treatment

    Introduction

    Pharmacologic Properties and Clinical Trial Findings

    Use of SUD Medications

    Strategies for Improving Use of SUD Medications

    Conclusion

    See also

    Section 4: Public Policy

    Chapter 70. Drug Decriminalization and Legalization

    Introduction

    Illicit Drug Use and Problems in Developed Countries

    Drug Crimes

    Decriminalization Options

    How Can We Tell What Works?

    Is Prohibition a Failure?

    Decriminalization Policies for Cannabis

    Decriminalization Policies for Heroin Use

    Conclusions

    See also

    Chapter 71. The Impact of Drink Driving Laws

    The Impact of Drink Driving Laws

    The Role of Alcohol in Road Traffic Crashes

    Traffic Law Enforcement

    Drink Driving Laws in Australia: A Case Study

    Conclusions

    See also

    Chapter 72. Effects of Licensing and Supply Practices

    Introduction

    Risky Products: Consumption and Consequences

    Availability as a Predictor of Consumption

    Reducing Availability: Legislation, Self-Regulation, and Co-Regulation

    Compliance with Legislation

    Monitoring and Improving Compliance with Legislation

    Conclusions

    See also

    Chapter 73. Marketing and Advertising Control

    What is this Chapter About?

    Addictions and Brain Function

    Advertising and Expectancies

    Cross-Sectional Studies

    Experimental Studies

    Longitudinal Studies

    Econometric Studies

    Self-Regulation

    See also

    Chapter 74. International Policies to Reduce Alcohol Consumption and Related Harms

    Introduction

    The Burden of Alcohol-Related Harm to Society and the Prevention Paradox

    Education and Persuasion Strategies

    Pricing and Taxation Approaches

    Reducing the Availability of Alcohol

    Regulating the Licensed Drinking Environment

    Conclusions

    See also

    Chapter 75. International Policies to Reduce Illicit Drug-Related Harm and Illicit Drug Use

    Introduction

    Harm Reduction Definition and Overview

    A History of Harm Reduction

    Harm Reduction Today: Primary Services

    A Sociological Analysis of Medical Harm Reduction

    Illicit Drug Use Reduction

    See also

    Chapter 76. International Policies to Reduce Tobacco Use

    Introduction

    Tobacco Industry

    Framework Convention on Tobacco Control

    Measures to Regulate the Supply of Tobacco Products

    Funding

    Chapter 77. Policies and Interventions to Reduce HIV Risk

    The Association between Drug Use and HIV Risk

    Policies and Interventions Addressing HIV and Drug Use

    Summary

    Section 5: Alcohol and Drug Prevention, Adolescents and College Students, Gambling

    Chapter 78. Alcohol Misuse Prevention in the Military

    The Alcohol Misuse Problem in the Military

    Prevention and Policy Approach

    Military Alcohol Misuse Prevention Programs

    Approaches to Encourage Responsible Drinking

    Summary and Future Directions

    Chapter 79. Screening and Assessment of Substance Use Disorders in Youth and Young Adults

    Introduction

    Developmental Considerations

    Screening and Assessment: Definitions and Goals

    Screening and Assessment Tools for Alcohol and Other Drugs

    Clinical Implications and Future Directions

    See also

    Chapter 80. Screening and Brief Alcohol Intervention for Adolescents and Young Adults in Primary Care and Emergency Settings

    Alcohol, Young People, and the Role of Health Care

    Missed Opportunities for SBIS: Adolescents and Health Care

    Summary of Guidelines and Recommendations

    SBI and SBIRTs for Adolescents in Health Care Settings

    Screening Methods

    Why Intervene in Medical Settings?

    Referral

    Roadblocks to Screening and Brief Intervention in Health Care Settings

    Alcohol, Trauma, and SBIRTS

    Forward Thinking

    Summary

    See also

    Chapter 81. Individual Prevention of College Student Alcohol Misuse

    Epidemiology of College Student Drinking

    College Student Drinking Prevention

    Individual-Focused Preventive Intervention Approaches

    Evidence of Efficacy for Specific Individual-Focused Preventive Intervention Approaches

    See also

    Chapter 82. Etiology and Prevention of Stimulants (Including Cocaine, Amphetamines and Misuse of Prescription Stimulants)

    History of Stimulant Use

    Current Epidemiology of Stimulant Use

    Neurobiology of Stimulants

    Treatments

    Psychological Interventions for Cocaine and Amphetamine Addiction

    Prevention

    Conclusions

    See also

    Chapter 83. Etiology and Prevention of Marijuana Use among College Students

    Prevalence and Development of Marijuana Use among College Students

    Dependence Risk and Marijuana-Related Consequences

    Intervention and Prevention Programs for College Students

    Challenges

    Conclusion

    See also

    Chapter 84. Performance-Enhancing Drug Use (Including Anabolic Steroids) by Adolescents and College Students: Etiology and Prevention

    Introduction

    The Social Context

    Prevalence of PED Use

    Etiological Considerations

    Consequences of PED Use in Adolescents and Young Adults

    Treatment and Prevention of PED use

    Dispelling the Myths of PED use

    Chapter 85. Substance Use Prevention Approaches for School-Aged Youth

    Overview of Substance Use Prevention

    Substance Use Prevention for Youth: A Multi-Level Approach

    Summary

    See also

    Chapter 86. Using the Internet for Alcohol and Drug Prevention

    Introduction

    Internet-Based Screening and Brief Intervention Resources for Adult Problem Drinking

    Pros and Cons of ISBIs

    Availability, Acceptability, and User Profiles of ISBIs

    Are ISBIs Effective in Curbing Adult Problem Drinking?

    Summary, Future Directions, and Conclusions

    Internet Interventions for Illicit Drug Use

    Interventions for Cannabis Use

    Interventions as Adjuncts to Pharmacotherapy

    Limitations of Existing Research

    Conclusions

    Chapter 87. Examining the Role of Parents in College Student Alcohol Etiology and Prevention

    Introduction

    The Role of Parents in the Etiology of College Student Drinking

    Examining the Efficacy of PBI

    Discussion

    Limitations and Future Directions

    See also

    Chapter 88. Universal, Indicated, and Selective Prevention for Youth Gambling

    Gambling and Pathological Gambling among Youth

    Universal Prevention

    Selective Prevention

    Indicated Prevention

    Conclusion

    See also

    Chapter 89. College Student Gambling: Etiology, Consequences, and Prevention Strategies

    Gambling Overview

    Prevalence of College Student Gambling

    Etiological Factors Related to College Student Gambling

    Harms Associated with Gambling

    Gambling Prevention

    Conclusions

    See also

    Chapter 90. Mobilizing Communities for Alcohol, Drug, and Tobacco Prevention

    What Does It Mean to Mobilize Communities to Prevent Drug Use?

    What Community-Based Strategies Work to Reduce Drug Use?

    Reliance on Community Coalitions to Prevent Drug Use

    Inclusion of School-Based Curricula in Community-Based Efforts

    Targeting Environmental Risk Factors for Substance Use

    Challenges of Community Mobilization Efforts

    Need for More Research

    See also

    Chapter 91. Impact of Alcohol Policies on College Student Health (Including Alcohol Access Restrictions, Policy Enforcement, Amnesty Policies)

    Introduction

    Policies to Reduce Access to Alcohol among Underage College Students

    Policies to Reduce Access to Alcohol: All Students

    Other Promising Policies for Addressing College Student Drinking

    Importance of Using Multiple Policy Strategies to Target College Student Drinking

    Conclusion

    See also

    Chapter 92. Alcohol Advertising and Underage Drinking

    Introduction

    Conclusions

    See also

    Chapter 93. The Impact of Price and Taxation on Drinking and Related Problems among Youth and Young Adults

    How Tax and Price Policies Work

    How These Policies Are Evaluated

    Empirical Evidence of Tax and Price Effects across All Ages

    Empirical Evidence of Tax and Price Effects among Youth and Young Adults

    Summary and Conclusions

    See also

    Chapter 94. Impact of Tobacco Control Policies on Youth Smoking Rates

    Introduction

    Restrictions on Sales and Distribution

    Smokefree Laws

    Economic Approaches

    Marketing and Promotion

    Conclusions

    See also

    Chapter 95. History and Impact of Minimum Legal Drinking Age Laws on Alcohol Use and Consequences among Adolescents and College Students

    Minimum Legal Drinking Age

    Drinking Ages Around the World

    Harmful Use of Alcohol

    History of Minimum Drinking Age Laws in the United States

    Evidence in Support of the Effectiveness of MLDA-21 in the United States

    Reductions in Homicides and Suicides Associated with MLDA-21 Laws

    Consequences of Alcohol Misuse among Adolescents

    Early Onset of Drinking

    MLDA-18 versus MLDA-21

    Lower Drinking Ages in Europe

    Binge Drinking by Youth

    College Binge Drinking

    Enforcement of MLDA Laws

    Summary

    See also

    Chapter 96. Understanding Individual Variation in Student Alcohol Use

    Overview

    Family History and Genetic Influences on Alcohol-Use Disorders

    Drinking Motives

    Personality Factors

    Precollege Drinking and Maturing Out of College Drinking

    Alcohol Expectancies

    Drinking Norms

    Summary

    Index

Product details

  • No. of pages: 1000
  • Language: English
  • Copyright: © Academic Press 2013
  • Published: February 26, 2013
  • Imprint: Academic Press
  • eBook ISBN: 9780123983633

About the Editor in Chief

Peter Miller

Peter M. Miller, Ph.D., is a clinical psychologist and Professor of Psychiatry and Behavioral Sciences in the Center for Drug and Alcohol Programs at the Medical University of South Carolina. He is Editor-in-Chief of the journal Addictive Behaviors and an experienced researcher and clinician in the field of alcohol use disorders.

Affiliations and Expertise

Medical University of South Carolina, Charleston, USA